• 2010

Company Description

Synpromics develops and commercializes synthetic promoters to control gene expressions and regulations.

Synpromics develops and commercializes synthetic promoters to control gene expressions and regulations. The company was founded in 2010 and is based in Edinburgh, United Kingdom.